跳至主要内容
临床试验/NCT04517032
NCT04517032Unknown不适用

ColoRectal Cancer in India: catastrOphiC expenDIture and Referral Pathways infLuencE on Presentation and Treatment

University of Birmingham0 个研究点目标入组 200 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
主要终点
Catastrophic Expenditure at 6 months

研究概览

简要总结

Observational study to assess barriers for colorectal cancer treatment compliance in India, including quantitative assessment of catastrophic expenditure incidence and qualitative assessment of financial and non-financial barriers.

详细描述

Objective: To identify a vulnerable group of colorectal cancer patients in India who cannot afford or are unable to comply with a treatment plan for colorectal cancer.

Aims:

  1. To identify the proportion of CRC patients suffering catastrophic expenditure due to out-of-pocket payments for cancer treatment.
  2. To determine the proportion of patients who are unable to comply with the treatment plan for CRC, at 6 weeks, 3 months and 6 months after diagnosis.
  3. To identify barriers and solutions to CRC treatment compliance. Design: A mixed-methods study comprising quantitative pilot data from 3 tertiary cancer centres and qualitative work from interviews with patients and healthcare professionals.

Participants: Patients diagnosed with primary colorectal cancer.

Outcomes:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Catastrophic Expenditure at 6 months

时间窗: 6 months after treatment decision

Catastrophic expenditure (CE) will be defined as out of pocket payments for CRC treatment greater than 40% of patient income (assessed by an in-person questionnaire led by a researcher).

次要结局

  • Identification of the main drivers of treatment cost(6 months after treatment decision)
  • Colorectal cancer stage at the time of diagnosis(At the time of colorectal cancer diagnosis (coincident with timing of patient enrolment in the study))
  • Catastrophic Expenditure at 6 weeks(6 weeks after treatment decision)
  • Catastrophic Expenditure at 3 months(3 months after treatment decision)
  • Treatment compliance at 6 weeks(6 weeks after treatment decision)
  • Treatment compliance at 3 months(3 months after treatment decision)
  • Treatment compliance at 6 months(6 months after treatment decision)

研究者

申办方类型
Other
责任方
Sponsor

相似试验